EFFECT OF D-FENFLURAMINE ON THE INDOLE CONTENTS OF THE RAT-BRAIN AFTER TREATMENT WITH DIFFERENT INDUCERS OF CYTOCHROME-P450 ISOENZYMES

Citation
M. Anelli et al., EFFECT OF D-FENFLURAMINE ON THE INDOLE CONTENTS OF THE RAT-BRAIN AFTER TREATMENT WITH DIFFERENT INDUCERS OF CYTOCHROME-P450 ISOENZYMES, Psychopharmacology, 118(2), 1995, pp. 188-194
Citations number
29
Categorie Soggetti
Neurosciences,Psychiatry,"Pharmacology & Pharmacy",Neurosciences,Psychiatry,"Pharmacology & Pharmacy
Journal title
Volume
118
Issue
2
Year of publication
1995
Pages
188 - 194
Database
ISI
SICI code
Abstract
The effects of pretreatment with inducers of hepatic cytochrome P450 i soenzymes (phenobarbital, dexamethasone and beta-naphthoflavone) on th e metabolism of d-fenfluramine (d-F) and its acute and long-lasting in dole-depleting effects were studied in rats, in an effort to obtain fu rther information on the importance of hepatic drug metabolism in rela tion to its neurochemical actions. Twenty-four hours after the last do se of each inducer, rats were injected with d-F hydrochloride (5 mg/kg , IP) and killed at various times thereafter for parallel determinatio n of indoles and drug concentrations in plasma and brain. Additional r ats were treated as above and killed 1 week after d-F hydrochloride (5 and 10 mg/kg) to study the recovery of indole in the cortex, a partic ularly sensitive brain area. Phenobarbital and beta-naphthoflavone and , to a lesser degree, dexamethasone, stimulated the metabolism of d-F, as evidenced by a decrease in plasma and brain areas under the curve (AUC) compared to vehicle-treated rats. This indicated that multiple i soenzymes are capable of mediating the drug's metabolism, primarily by N-dealkylation to d-norfenfluramine (d-NF). None of the inducers rais ed plasma and brain AUC of the nor-derivative, and in fact phenobarbit al and particularly beta-naphthoflavone reduced it. These different ef fects were even apparent in rats given d-NF (2.5 mg/kg), indicating th at both phenobarbital and beta-naphthoflavone also stimulate the seque ntial metabolism of the nor-metabolite (by N-deamination) which, howev er, is apparently enhanced most actively by beta-naphthoflavone-induci ble forms of P-450. Total ''active'' brain concentrations (d-F + d-NF) after the different pretreatments were in the order of beta-naphthofl avone < phenobarbital < dexamethasone less than or equal to vehicle. I nterestingly, beta-naphthoflavone rapidly reversed the depletion of br ain indoles caused by d-F (and d-NF); phenobarbital provided partial p rotection and dexamethasone did not appreciably modify either the acut e or long-term neurochemical effects of the drug. The fact that phenob arbital affected d-NF kinetics less than beta-naphthoflavone, and prov ided only partial protection against the acute and long-lasting neuroc hemical effects of high doses of d-F, further stresses the critical ro le of d-NF in the neurochemical outcome of its parent drug. These find ings support the view that the degree and duration of the indole-deple ting effects are related to critical brain concentrations of the paren t compound and its nor-derivative, and provide indirect evidence that hepatic metabolites other than d-NF are unlikely to play any role in t he neurochemical effects of high doses of d-F in rats.